chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My entire right eye swelled and drooped down along with my mouth around 8 AM 9/20, it got progressively better during the day 9/20 and then overnight I had heart attack like chest pains leading into 9/21.  It felt like an elephant was on my chest and I was having a heart attack. I went to the ER 9/21
Shingrix #1 effect: 10/20/18 at bedtime developed ringing in left ear for 2 min, followed by greatly diminished hearing in left ear. Left ear continues to have ringing and continued noticeable diminished hearing loss. Hearing test performed 3/25/2019 at audiology clinic. Result is extremely noticeable hearing deficit and now referred to ENT provider for follow up. Shingrix #2 effect: Acute onset severe pain to injection site three hours after vaccine administered. Pain involved left shoulder and forearm. No relief with TYLENOL or topical ice/heat to area. Unable to use left arm/hand at all for next 48 hours post injection. Missed one day of work due to extreme left arm pain. Continue to have limited range of motion to left shoulder and pain to left shoulder if sleeping on left side.
November 1st while at work and before work, I felt exaberated and very dizzy.  Nov 2nd continued to feel nausea and dizzy and between legs weak, losing feeling in my legs, unable to work.  By Nov 7th, increased dizziness, increased weakness in legs and now my back and arms.
The major event was the loss of taste in the middle of my tongue. I had it, and after a month it started to go away. After getting my second dose it came back then went away. It was just the middle of my tongue; my smell was fine.
Was tested and urgent care on 12/21. Came in to ED on 12/25 for worsening symptoms. Hx of asthma
Immediate pain in left deltoid after injection. described as a "fire sensation". Then within a couple minutes the pain spread across her shoulder to her upper chest. Her co-worker noticed her upper chest was flushed. She then developed throat tightness and difficulty breathing. Had associated dizziness and nausea. Was given 0.3mg of epinephrine in the left thigh via auto-injector. Symptoms rapidly improved. Transported to ER for monitoring.
The area surrounding the injection site developed a round rash, hot to touch, and swollen. This occured about a week after vaccine.
Based on Immunization Registry report, resident previously received a booster dose of Moderna on 11/15/2021. Pharmacy and Assisted Living Facility were unaware as dose was not documented on CDC vaccine card.
Moderna vial opened on 3/23/22 @ 10:30am and administered this patient dose on 3/24/22 @ 3:05pm. Per manufacturer guidelines, dose administered beyond-use date Pt did not experience any adverse side effects at time of event
Around 11PM on 1/23 when I was getting ready for bed I noticed a rash on my chest and back and that my tongue was swelling.  I took some Benadryl and the symptoms resolved.  I woke up around 6AM on 1/24 and the symptoms were back.  I took more Benadryl and the symptoms resolved .  Around 1:30Pm on 1/24 symptoms reappeared took more Benadryl and decided to go the ER at 2:30PM.  When I got there the symptoms had resolved again  The Doctor determined that  my Asthma had been exacerbated by the Vaccine.I was treated with intravenous steroids and Benadryl.  I was also treated by the Respiratory HCP with Albuterol - 4 puffs at 3:30PM and again at 6:00PM with 2 puffs of Albuterol.  I was given a prescription for Prednisone 50mg  for 5 days. I was released at 6;30PM.   I felt fine after coming home.  I saw my healthcare specialist on 1/25.  It was a scheduled appt.  and I told him about my side effects and he told me to please report them to you and to my Primary healthcare provider.
This spontaneous report as received from a health professional refers to a 10 week old female patient. Medical history and current conditions were not reported. On 09-DEC-2014, the patient was vaccinated with the first dose of ROTATEQ, 2 ml, orally (lot number reported as: K010755, expiration date: 19-MAY-2016). Concomitant medication was not reported. On 23-DEC-2014, the patient's mother called the office and was advised to go to the emergency room at the hospital. The patient then was diagnosed with intussusception, was hospitalized and had a surgery to correct it. The outcome of intussusception was unknown. The reporter considered the event to be life threatening. Additional information has been requested.
Chest pains; shortness of breath; dizzyness; heart skips a beat sometimes, heart beats too fast; heat flashes; This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 25Apr2021 (at the age of 46 years old) as a DOSE 2, SINGLE for COVID-19 immunisation. Medical history was none reported. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was tested for COVID-19. The patient did not have any known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Lot number: ER8733) in left arm on 03Apr2021 (at the age of 46 years old) for covid-19 immunisation. On 04Jun2021 at 17:30 the patient experienced Chest pains, shortness of breath, dizzyness, heart skips a beat sometimes, heart beats too fast sometimes when resting followed by heat flashes. CT scan and blood work all looked healthy. The patient visited Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient did not receive any treatment for the events. The patient underwent lab tests and procedures which included blood work, CT scan and resulted all looked healthy and heart beats was fast on 04Jun2021 while on 14Jun2021 SARS-CoV-2 (COVID-19) RT-PCR was done and resulted negative. The outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Rash from latex: Rx steroid ointment for earlier unrelated rash, Benadryl  Wine flush/congestion: nothing Face swelling/redness/shortness of breath: Benadryl
Headache, vomiting, nausea.  Initial report received on 11 April 2008 from a nurse practitioner. A 22 year old female patient received on 26 March 2008 a subcutaneous left arm injection of IPOL (Lot#20474-2), an intramuscular left deltoid injection of FLUSONE (lot#U2479BA) and a first intramuscular right deltoid injection of HAVRIX (GSK, lot#AHAVB144AD). On 28 March 2008, two days post vaccination, the patient developed nausea, vomiting, and a headache for 24 hours. corrective treatment was not reported. The patient had no previous medical history and her only medication was ORTHO TRI-CYCLIN. At the time of the report, 11 April 2008, the patient had recovered.
Shortly after receiving the Covid vaccine EE states she has a dry throat, water given, the stated, "It feels like it did when I had my allergic reaction to Gain detergent. Seriously feels like I have cotton balls in my throat and it seems to be getting worse. Rapid response team notified, observed, monitored and reassured EE BP 156/74 HR 89 O2 sat 99%, BP 141/70 HR 81, O2 sat 99% EE was allowed to go home after close obs for greater than 30 min EE states she felt anxious and just wanted to go home, her mom was picking her up and bringing Benadryl with her
I slipped on the ice and fell in January 2022, a year after my first Moderna dose, and injured my right knee. X-rays were normal, but I have had a lot of pain since then, probably due to a pulled hamstring followed by increased sharp pain on her anteromedial R knee. I received physical therapy for these problems and am scheduled to see an orthopedist on 03/15/22.
pt recvd vax;fever,chills,HA,n,stomach cramps & d;
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects after Moderna COVID-19 shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects after Moderna COVID-19 shot). At the time of the report, VACCINATION COMPLICATION (side effects after Moderna COVID-19 shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication reported. No treatment information was provided.
Information has been received from a nurse practitioner, for the pregnancy registry for GARDASIL concerning a 6 day old female. Her 22 year old mother was vaccinated with the first 0.5 ml dose of GARDASIL (lot# 660555/0279X) on 07-JUL-2008. On 10-OCT-2008 the patient received the second 0.5 ml dose of GARDASIL (lot# 660620/0571X). LMP was 17-SEP-2008. Estimated delivery date was 24-Jun-2009. On 26-JUN-2009 (40.4 gestation weeks), the mother delivered a normal female baby (6 pounds and 4.8 ounce, 20.5 length, head circumference 12, apgar score 9/9, no congenital anomalies and no other complications or abnormalities). On 01-JUL-2009, 6 day after birth, the baby was found have bilateral small subconjunctive hemorrhage. Routine newborn care handout was given. On 04-JUL-2009, the mother called doctor on call that the baby experienced constipation. She was instructed to add light karo syrup to bottle. If not stool again, add dark karo to bottle. One top was 2 ounce. One bottle was on 06-JUL-2009 and one on 07-JUL-2009. The mother could call back if the baby was not stooling well 7 to 8 days later. Small wet gerps was described by now. The mother's experience has been captured in WAES 0810USA03940. Additional information has been requested.
Patient presented to a vaccination clinic on 10/05/2022 @1205 patient was given a Covid Pfizer Monovalent vaccine by accident. The intended vaccination was Covid Pfizer Bivalent vaccine. No adverse reactions were noted, patient educated on the need for revaccination with correct Pfizer Bivalent vaccine.
Pt developed an injection site reaction characterized by a very large red, raised area measuring 4 inches, which resolved after 10 days.
the outer part of her right thigh went completely numb, leg was numb; This is a spontaneous report from a contactable consumer (patient). A 20-year-old female patient of unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Unknown, Expiration date: Unknown), via an unspecified route in the left arm on 11May2021 (age at vaccination: 20-year-old), as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), as a single dose of covid-19 immunization. On 12May2021 around 11:30, patient stated that outer part of her right thigh went completely numb and states that it has been like that for a little over 24 hours now. She got the shot in left arm but, she is not sure why her leg was numb. Patient would like to know if this is normal with the vaccine. The clinical outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a pharmacist concerning an 18 month old female who was accidentally vaccinated with a dose of Zostavax instead of a dose of Varivax. The patient was not experiencing any known symptoms. The reporter did not know why this happened. Additional information has been requested.
This case was reported by a nurse via call center representative and described the occurrence of headache in a 63-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a day after receiving SHINGRIX, the patient experienced headache, chills, cutaneous hypersensitivity and fever. On an unknown date, the outcome of the headache, chills, cutaneous hypersensitivity and fever were recovered/resolved. It was unknown if the reporter considered the headache, chills, cutaneous hypersensitivity and fever to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported but it could be 62 or 63 years. On the evening of the patient received SHINGRIX, she had a splitting headache, fever, chills and skin hypersensitivity. All the adverse events had cleared up by the next day.
pt recv vax 21SEP94 & the next day pt devel a red itchy splotch on abd, draining of ears into throat, reoccurrences of athlete's feet w/breaking out, itching & face broke out; pt recovered p/4 days;
Have Dercum's Disease and noticed that my lipomas have more than doubled in size and my fatigue has become way worse than it was. I did not think that the vaccine caused it until other people in my Dercums support group started asking if it was happening to others after they received the vaccine.
Patient was checked in and registered for his first dose of the pfizer vaccine but after the administration upon recording it was discovered this was his third dose. He had gotten his second dose on 9/20/21
Pt reports post vaccine N/V, dizziness, muscle pain in neck,shoulders, arms, legs, weakness of extremities. Small area of fine rash on chest.
cranky, fussing evening of 12AUG97 visited ER on 13AUG97 w/above sx & fever 013R;MD stated sx probably from immun;
04/09/21 woke up with body aches, fever, sore throat,  headache & nausea, was sick all day couldnt go to work. -  04/10/21 next day was still sick and i started having menstrual  cramps and i have been in menopause for at least 3 -4 years.  symptoms began to subside on 04/10/21 and i was able to return to work on 04/11/21.
Patient develop hives 8 hours after receiving vaccinations. The patient called a nurse for advice. The patient took Benadryl 50 mg 2 times 6 hours apart. The next day the hives were gone.
Sm noted erythematous, pruritic papules on chest that have now spread to his axillary area following vaccination with primary SPV. Actually date of SPV inoculation was 9/9/08. Symptoms: Lesions, papule, Erythema, Pruritus.
After receiving vaccination he waited for 15 minutes of observation, later he mentioned he felt fatigue due to working/driving until 2AM and not eating.  We gave him water and other snacks.  He was under observation for about 30 minutes, he was talking, walking and eating. It was not observed any health related issues or concerns. After that he said he is feeling better and left the vaccination site on his own volition. He was encouraged to report any side effect to V-Safe.
Information has been received from a physician concerning an 18 year old female with no pertinent medical history and no known drug allergies, who on 18-NOV-2009 was vaccinated with the first dose of GARDASIL (lot # 661758/0968Y) in the left deltoid. There was no concomitant medication. On 19-NOV-2009 the patient's mother called the office stating her child had total numbness and tingling of upper left side of body, the same side as the site of vaccination. On 20-NOV-2009 another phone call from the mother stated the patient had itchy rash on her abdomen and face. The patient sought unspecified medical attention. At the time of the report, the patient had not recovered. Follow up information has been received from a physician concerning an 18 year old female without illness at time of vaccination and no known drug allergies, who on 18-NOV-2009 in the AM was vaccinated with the first dose of GARDASIL (lot # 661758/0968Y) IM in the left deltoid. On 19-NOV-2009 the patient reported she had numbness and tingling of entire left side of body. On 21-NOV-2009, the patient developed rash on trunk initially and spread to face and chin, which was raised, pruritic pustule-like. There were no labs or diagnostic tests performed. The outcome was unknown. No further information is available.
Ever since received xxxx vaccine 10/22/14. Since then  xxx, xxx, falling a lot and xxxx or throwing things, hyperactive but agreeable.
Pt received MMR and DTaP in left arm on Wednesday and developed redness, swelling, tenderness evening of Wednesday, Aug 2. Mom brought boy to office Friday afternoon. H had erythema, swelling of left arm with tenderness to palpation. Mom treated pain with Motrin. Child afebrile, no other systemic symptoms. We treated him symptomatically with Benadryl, Motrin and cool compresses. Gave mom instructions to return if symptoms worsened or systemic sys like fever developed.
Pt had shot during day & began having vomiting & diarrhea that evening, getting worse on following 2 days; pt taken to ER afternoon of the 11th-diarrhea had stopped but was still vomiting; 12FEB pt pale, tired & unable to retain food/fluids
1st dose of Havrix on 31AUG2023 and 2nd dose of Havrix on 01NOV2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 67-year-old female patient who received HAV (Havrix 1440 adult) (batch number T9TL9, expiry date 05-DEC-2025) for prophylaxis.   Concomitant products included HEPATITIS A VACCINE (HAVRIX 1440 ADULT).   On 01-NOV-2023, the patient received the 2nd dose of Havrix 1440 adult (intramuscular). On 01-NOV-2023, an unknown time after receiving Havrix 1440 adult, the patient experienced drug dose administration interval too short (Verbatim: 1st dose of Havrix on 31AUG2023 and 2nd dose of Havrix on 01NOV2023. Lot# and Expiration dates are same for both doses of vaccines). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK receipt date: 1-Nov-2023 The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. The patient received 2nd dose of Havrix earlier than the recommended interval, which led to shortening of vaccine schedule.
11/1/22  had STEMI thought to be due to embolic thrombi requiring aspiration thrombectomy.  11/2 /22 had another STEMI due to embolic thrombi requiring aspiration thrombectomy.   Patient is a 36-year-old man with history of hypertension and possible MI (age 21, self-reported) who presented with acute onset substernal chest pain radiating to both arms and was found to have STEMI with 100% occlusions with thrombi (no underlying plaque) of both LAD and RCA now s/p aspiration and thrombectomy of both arteries on 11/1 c/b persistent ST elevation, then found to have 100% occluded posterolateral branch artery in the setting of heavy thrombus burden s/p second aspiration thrombectomy and stent placement on 11/2. He was then started on DAPT and apixaban, with plan for triple therapy (DAPT/apixaban) for a month (stop aspirin 12/1/22) followed by dual therapy (P2y12/DOAC) for at least 1 year. Hypercoagulable workup was unrevealing.
Information has been received from a pharmacist referring to a patient of unknown age and gender. No relevant medical history or concurrent conditions were reported. On 19-MAY-2016, the patient was inadvertently vaccinated with an expired dose of RECOMBIVAX HB injection 10Y (lot # J007946, expiration date 24-MAR-2016; dose and route were not reported). No adverse effect was reported. Additional information has been requested.
I got shingles by getting this shock/Suspected vaccination failure; I got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 3-Sept-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient got shingles by getting this shock. The patient was currently 55 years with shingles. The patient have had to have monthly shots that cost 1000 dollars. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Shortness of breath; Discomfort on her chest; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Discomfort on her chest) and DYSPNOEA (Shortness of breath) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006b21a and 017c21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 11-Oct-2021, the patient experienced CHEST DISCOMFORT (Discomfort on her chest) (seriousness criterion medically significant). On 12-Oct-2021, the patient experienced DYSPNOEA (Shortness of breath) (seriousness criterion medically significant). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 05-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, CHEST DISCOMFORT (Discomfort on her chest) and DYSPNOEA (Shortness of breath) had not resolved.            Other concomitant medication reported was unspecified blood pressure medication.  Company comment: This case concerns a 58-year-old, female patient with no reported relevant medical history, who experienced the serious events of dyspnoea and chest discomfort. The events occurred approximately 4 months after the second dose of Spikevax. The rechallenge was not applicable as the events occurred after the second dose, no additional dose is expected to be given, and no details were provided about the first dose. Although no medical history was reported, patient's concomitant medication includes a blood pressure medicine, condition which could be a confounding factor. The benefit-risk relationship of Spikevax is not affected by this report.   This case was linked to MOD-2021-350382 (Patient Link).; Sender's Comments: This case concerns a 58-year-old, female patient with no reported relevant medical history, who experienced the serious events of dyspnoea and chest discomfort. The events occurred approximately 4 months after the second dose of Spikevax. The rechallenge was not applicable as the events occurred after the second dose, no additional dose is expected to be given, and no details were provided about the first dose. Although no medical history was reported, patient's concomitant medication includes a blood pressure medicine, condition which could be a confounding factor. The benefit-risk relationship of Spikevax is not affected by this report.
3-4 inch cellulitis rounded swelling on left hip (thigh); no apparent pain.